Patents by Inventor Sarah M. Ward

Sarah M. Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11912709
    Abstract: A temozolomide compound according to formula (I) is described, wherein R1, L1, and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: February 27, 2024
    Assignee: UNIVERSITY OF MASSACHUSETTS
    Inventors: Todd Emrick, Matthew Skinner, Sarah M. Ward, Banishree Saha
  • Publication number: 20210198265
    Abstract: A temozolomide compound according to formula (I) is described, wherein R1, L1, and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.
    Type: Application
    Filed: March 1, 2021
    Publication date: July 1, 2021
    Inventors: Todd Emrick, Matthew Skinner, Sarah M. Ward, Banishree Saha
  • Patent number: 10995094
    Abstract: A temozolomide compound according to formula (I) is described, wherein R1, L1, and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: May 4, 2021
    Assignee: THE UNIVERSITY OF MASSACHUSETTS
    Inventors: Todd Emrick, Matthew Skinner, Sarah M. Ward, Banishree Saha
  • Publication number: 20200140448
    Abstract: A temozolomide compound according to formula (I) is described, wherein R1, L1, and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 7, 2020
    Inventors: Todd Emrick, Matthew Skinner, Sarah M. Ward, Banishree Saha
  • Patent number: 10562901
    Abstract: A temozolomide compound according to formula (I) is described, wherein R1, L1, and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: February 18, 2020
    Assignee: THE UNIVERSITY OF MASSACHUSETTS
    Inventors: Todd Emrick, Matthew Skinner, Sarah M. Ward, Banishree Saha
  • Publication number: 20180079754
    Abstract: A temozolomide compound according to formula (I) is described, wherein R1, L1, and X are defined herein. The temozolomide compound can be used to prepare polymers comprising temozolomide. Additionally, the polymers comprising temozolomide can be particularly useful in the treatment of certain diseases.
    Type: Application
    Filed: September 20, 2017
    Publication date: March 22, 2018
    Inventors: Todd Emrick, Matthew Skinner, Sarah M. Ward, Banishree Saha
  • Patent number: 5304718
    Abstract: The present invention is directed to the use of a Apelawa variety of quinoa in the production of cytoplasmic male sterile quinoa plants and seeds useful in breeding programs for high-yield quinoa hybrids. More particularly, the present invention is directed to the use of cytoplasmic male sterile plants of the Apelawa variety of quinoa to produce plants and seeds for lines of quinoa varieties having male sterile cytoplasm; to cytoplasmic male sterile quinoa plants; quinoa seeds for cytoplasmic male sterile plants; and methods of producing cytoplasmic male sterile quinoa plants and seeds to create a source of cytoplasmic male sterile quinoa plants. A quinoa seed having male sterile cytoplasm and assigned ATCC accession no. 75154 is specifically disclosed.
    Type: Grant
    Filed: February 3, 1992
    Date of Patent: April 19, 1994
    Assignee: Research Corporation Technologies, Inc.
    Inventors: Sarah M. Ward, Duane L. Johnson